Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 27, 2016
Insertion stability of poly(ethylene glycol)-cholesteryl-based lipid anchors in liposome membranesDaniel Molnar, Jürgen Linders, Christian Mayer, et al.Proceedings. Mathematical, Physical, and Engineering Sciences|February 14, 2022
Interaction between surface waves on wire linesDaniel Molnar, Tobias Schaich, Anas Al-Rawi, et al.Scientific Reports|November 28, 2020
Analytic modelling of a planar Goubau line with circular conductorTobias Schaich, Daniel Molnar, Anas Al Rawi, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 13, 2025
Impact of vial quality on interactions, particle formation, container closure integrity, and gas permeability for frozen drug product storageDaniela Henle, Lukas Muehlfeld, Daniel Molnar, et al.Journal of Pharmaceutical Sciences|August 5, 2026
Understanding vial strain during freezing of aqueous solutions-Part I: A combined approach of experimental strain gauge measurements and computer simulationsDaniela Henle, Lukas Muehlfeld, Kai Berkenfeld, et al.Expert Review of Vaccines|October 22, 2024
Cost-effectiveness analysis of respiratory syncytial virus vaccination with the adjuvanted prefusion F protein vaccine (RSVPreF3 OA) for adults ≥60 years old in JapanAkiko Mizukami, Victor Preckler, Frederik Verelst, et al.Infectious Diseases and Therapy|October 11, 2025
Public Health Impact and Cost-Effectiveness of Adjuvanted RSVPreF3 Vaccination among Adults in the USA Aged 50-59 Years at Increased Risk of Severe RSV DiseaseDavid Singer, Elizabeth M La, Jonathan Graham, et al.Journal of Physics. Condensed Matter : an Institute of Physics Journal|March 14, 2015
Effects of stoichiometric doping in superconducting Bi-O-S compoundsCorentin Morice, Emilio Artacho, Siân E Dutton, et al.Expert Review of Vaccines|March 1, 2024
The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysisDaisuke Kurai, Akiko Mizukami, Victor Preckler, et al.Expert Review of Pharmacoeconomics & Outcomes Research|May 13, 2026
Estimating respiratory syncytial virus health utility values for older adults and their caregivers in the Japanese population: a time trade-off studyRegina Rendas-Baum, Jakob Bjorner, Victor Preckler, et al.Pageof 3